- Home
- BSRR vs ALDX Comparison
BSRR vs ALDX Comparison
Compare BSRR & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSRR
- ALDX
- Stock Information
- Founded
- BSRR 1977
- ALDX 2004
- Country
- BSRR United States
- ALDX United States
- Employees
- BSRR N/A
- ALDX N/A
- Industry
- BSRR Major Banks
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- BSRR Finance
- ALDX Health Care
- Exchange
- BSRR Nasdaq
- ALDX Nasdaq
- Market Cap
- BSRR 416.7M
- ALDX 342.3M
- IPO Year
- BSRR 1994
- ALDX 2014
- Fundamental
- Price
- BSRR $29.61
- ALDX $5.09
- Analyst Decision
- BSRR Buy
- ALDX Strong Buy
- Analyst Count
- BSRR 2
- ALDX 2
- Target Price
- BSRR $33.50
- ALDX $9.50
- AVG Volume (30 Days)
- BSRR 19.6K
- ALDX 776.7K
- Earning Date
- BSRR 10-20-2025
- ALDX 11-06-2025
- Dividend Yield
- BSRR 3.32%
- ALDX N/A
- EPS Growth
- BSRR 18.55
- ALDX N/A
- EPS
- BSRR 2.90
- ALDX N/A
- Revenue
- BSRR $145,369,000.00
- ALDX N/A
- Revenue This Year
- BSRR $8.30
- ALDX N/A
- Revenue Next Year
- BSRR $3.74
- ALDX $63.48
- P/E Ratio
- BSRR $10.39
- ALDX N/A
- Revenue Growth
- BSRR 2.12
- ALDX N/A
- 52 Week Low
- BSRR $22.42
- ALDX $1.14
- 52 Week High
- BSRR $35.13
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- BSRR 45.06
- ALDX 37.19
- Support Level
- BSRR $29.59
- ALDX $4.96
- Resistance Level
- BSRR $30.90
- ALDX $5.88
- Average True Range (ATR)
- BSRR 0.56
- ALDX 0.29
- MACD
- BSRR -0.09
- ALDX -0.11
- Stochastic Oscillator
- BSRR 0.95
- ALDX 8.64
About BSRR Sierra Bancorp
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.